Search
Tirzepatide
go.drugbank.com/drugs/DB15171ApprovedInvestigational[A246265] Tirzepatide was approved by the FDA on May 13, 2022, under the brand name MOUNJARO by the FDA for the treatment of adults with type 2 diabetes, making it the first and only GIP and GLP-1 receptor … [A246260] Tirzepatide comprises a 39 amino acid linear synthetic peptide conjugated to a C20 fatty diacid moiety.
Categories: Receptors, G-Protein-Coupled, GLP-1 AgonistsProducts: Mounjaro 5 mg/0,5 ml Enjeksiyonluk Çözelti, 4 ADET, Mounjaro 2,5 mg/0,5 ml Enjeksiyonluk Çözelti, 4 ADET(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
go.drugbank.com/drugs/DB07007ExperimentalSynonyms: (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amineDexchlorpheniramine maleate
go.drugbank.com/drugs/DB09555ApprovedDexchlorpheniramine is the S-enantiomer of chlorpheniramine which is a 1st generation anti-histamine. … Dexchlorpheniramine has more pharmacological activity than the R and so is more potent than the racemic mixture.
Mixtures: HUFADEXTA-M, INTUNAL-FCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 InhibitorsTT-232
go.drugbank.com/drugs/DB12088InvestigationalTln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
Synonyms: D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6)Salts: D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6) acetateSomatotropin
go.drugbank.com/drugs/DB00052ApprovedInvestigational[A228183, L31508] Synthesized in a strain of _Escherichia coli_, recombinant HGH is a polypeptide hormone that contains 191 amino acid residues with a molecular weight of 22 kDa. … [A228188] Recombinant growth hormone is available as a subcutaneous injection for children and adults under a wide variety of brand names.
Mixtures: Nutropin - Kit Pws(5mg) & Liq(10ml) Im ScCategories: P-glycoprotein substrates, Cytochrome P-450 CYP1A2 InducersMidazolam
go.drugbank.com/drugs/DB00683ApprovedIllicitInvestigationalMidazolam is a short-acting hypnotic-sedative drug with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties. … [A257153] Midazolam is considered a schedule IV drug in the United States due to the low potential for abuse and low risk of dependence.[L5074]
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: Midazolam-hameln 2 mg/ml Injektions-/Infusionslösung, OZASED 2 mg/ml Lösung zum Einnehmen im EinzeldosisbehältnisMyristyl glyceryl ether
go.drugbank.com/drugs/DB15662InvestigationalSynonyms: 3-Tetradecyloxy-1,2-propanediol, 1-o-tetradecylglycerolLuminol
go.drugbank.com/drugs/DB18536ExperimentalSynonyms: 3-aminophthalic hydrazide, O-aminophthalylhydrazideCategories: Heterocyclic Compounds, 1-Ring, Compounds used in a research, industrial, or household settingp-Toluenesulfonic acid
go.drugbank.com/drugs/DB03120ExperimentalSynonyms: 4-toluenesulfonic acid, toluene-4-sulfonic acid